| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | TRPM4 CXCR3 ABCA2 GPR27 F2RL3 GAS6 ABCB6 TF ADCY5 GSTP1 THADA BOK CCDC47 SCTR HTT SMAD4 PML | 1.70e-06 | 866 | 105 | 17 | GO:0055082 |
| GeneOntologyBiologicalProcess | chemical homeostasis | TRPM4 CXCR3 ABCA2 GPR27 F2RL3 GAS6 HECTD4 ABCB6 TF ADCY5 GSTP1 THADA FBN1 FBN2 BOK CCDC47 SCTR HTT SMAD4 PML | 4.27e-06 | 1249 | 105 | 20 | GO:0048878 |
| GeneOntologyBiologicalProcess | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 7.34e-06 | 53 | 105 | 5 | GO:0006890 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | TRPM4 CXCR3 ABCA2 GPR27 F2RL3 GAS6 ABCB6 TF ADCY5 GSTP1 THADA BOK CCDC47 SCTR HTT SMAD4 PML | 8.97e-06 | 981 | 105 | 17 | GO:0019725 |
| GeneOntologyBiologicalProcess | maintenance of location | 3.46e-05 | 396 | 105 | 10 | GO:0051235 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | SEL1L TRPM4 GPR27 SREBF1 COPG2 GOLPH3 ADCY5 FBN1 FBN2 AP1B1 HTT | 4.06e-05 | 490 | 105 | 11 | GO:0071692 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.53e-04 | 4 | 105 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | metal ion transport | TRPM4 CXCR3 F2RL3 GAS6 LMTK2 ABCB6 TF KCNK4 JAK3 TMEM168 NFATC1 SLC23A2 CRBN HTT PML | 1.61e-04 | 1000 | 105 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | protein secretion | 1.70e-04 | 480 | 105 | 10 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 1.79e-04 | 483 | 105 | 10 | GO:0035592 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrion organization | 1.81e-04 | 162 | 105 | 6 | GO:0010821 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPM4 CXCR3 F2RL3 GAS6 LMTK2 ABCB6 TF KCNK4 JAK3 PIEZO2 TMEM168 NFATC1 CLDN17 SLC19A1 SLC23A2 CRBN HTT PML | 1.86e-04 | 1374 | 105 | 18 | GO:0006811 |
| GeneOntologyCellularComponent | endosome | MON2 ABCA2 LAMTOR2 HDAC6 TRIO LMTK2 RAPGEF1 ABCB6 GOLPH3 TF ADCY5 JAK3 BOK AP1B1 AP2B1 STOML1 SLC35D3 CNTNAP2 HTT PML | 1.24e-06 | 1167 | 105 | 20 | GO:0005768 |
| GeneOntologyCellularComponent | early endosome | MON2 LMTK2 RAPGEF1 ABCB6 TF BOK AP1B1 SLC35D3 CNTNAP2 HTT PML | 3.04e-05 | 481 | 105 | 11 | GO:0005769 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 ABCA2 LAMTOR2 SREBF1 SLC2A14 RAPGEF1 ABCB6 COPG2 TF LRIG3 BOK AP1B1 AP2B1 STOML1 SLC35D3 HTT PML | 2.67e-04 | 1307 | 105 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MON2 ABCA2 LAMTOR2 SREBF1 SLC2A14 RAPGEF1 ABCB6 COPG2 TF LRIG3 BOK AP1B1 AP2B1 STOML1 SLC35D3 HTT PML | 3.14e-04 | 1325 | 105 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | vesicle coat | 3.61e-04 | 67 | 105 | 4 | GO:0030120 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 3.70e-04 | 6 | 105 | 2 | GO:0043190 | |
| GeneOntologyCellularComponent | coated vesicle | 4.68e-04 | 360 | 105 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 8.79e-04 | 9 | 105 | 2 | GO:0160064 | |
| GeneOntologyCellularComponent | endosome membrane | 9.04e-04 | 602 | 105 | 10 | GO:0010008 | |
| GeneOntologyCellularComponent | microfibril | 1.88e-03 | 13 | 105 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SEL1L CYP2D6 USE1 SREBF1 RDH14 ABCB6 COPG2 NCLN FAAH NBAS THADA BOK CCDC47 SLC35D3 PML | 2.00e-03 | 1293 | 105 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | membrane coat | 2.02e-03 | 106 | 105 | 4 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 2.02e-03 | 106 | 105 | 4 | GO:0048475 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SEL1L CYP2D6 USE1 SREBF1 RDH14 ABCB6 COPG2 NCLN FAAH NBAS THADA BOK CCDC47 SLC35D3 PML | 2.09e-03 | 1299 | 105 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.19e-03 | 14 | 105 | 2 | GO:0072379 | |
| Domain | ARM-like | MON2 MROH2A CUL9 COPG2 UNC45A IPO4 HEATR6 AP1B1 PELP1 AP2B1 ASPM HTT | 3.47e-08 | 270 | 104 | 12 | IPR011989 |
| Domain | ARM-type_fold | MON2 MROH2A CUL9 COPG2 UNC45A IPO4 THADA HEATR6 AP1B1 PELP1 AP2B1 ASPM HTT | 5.11e-08 | 339 | 104 | 13 | IPR016024 |
| Domain | - | 4.53e-07 | 222 | 104 | 10 | 1.25.10.10 | |
| Domain | Coatomer/calthrin_app_sub_C | 9.20e-06 | 8 | 104 | 3 | IPR009028 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 3.07e-05 | 2 | 104 | 2 | IPR013037 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 2.60.40.1150 | |
| Domain | ABC_A | 3.56e-05 | 12 | 104 | 3 | IPR026082 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.56e-05 | 12 | 104 | 3 | IPR013041 | |
| Domain | HEAT_REPEAT | 4.41e-05 | 70 | 104 | 5 | PS50077 | |
| Domain | Clathrin/coatomer_adapt-like_N | 7.27e-05 | 15 | 104 | 3 | IPR002553 | |
| Domain | Adaptin_N | 7.27e-05 | 15 | 104 | 3 | PF01602 | |
| Domain | AP_complex_bsu_1_2_4 | 9.18e-05 | 3 | 104 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 9.18e-05 | 3 | 104 | 2 | PF09066 | |
| Domain | FBN | 9.18e-05 | 3 | 104 | 2 | IPR011398 | |
| Domain | ABC_tran | 1.46e-04 | 48 | 104 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.46e-04 | 48 | 104 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.59e-04 | 49 | 104 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.72e-04 | 50 | 104 | 4 | IPR003439 | |
| Domain | rSAM_horseshoe | 1.83e-04 | 4 | 104 | 2 | IPR023404 | |
| Domain | B2-adapt-app_C | 1.83e-04 | 4 | 104 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 1.83e-04 | 4 | 104 | 2 | IPR015151 | |
| Domain | - | 1.83e-04 | 4 | 104 | 2 | 3.80.30.20 | |
| Domain | AP_beta | 3.04e-04 | 5 | 104 | 2 | IPR026739 | |
| Domain | cEGF | 3.97e-04 | 26 | 104 | 3 | PF12662 | |
| Domain | cEGF | 3.97e-04 | 26 | 104 | 3 | IPR026823 | |
| Domain | Beta2_adaptin/TBP_C_dom | 4.54e-04 | 6 | 104 | 2 | IPR012295 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 3.30.310.10 | |
| Domain | CAMSAP_CH | 6.33e-04 | 7 | 104 | 2 | PF11971 | |
| Domain | Elp3 | 6.33e-04 | 7 | 104 | 2 | SM00729 | |
| Domain | TB | 6.33e-04 | 7 | 104 | 2 | PF00683 | |
| Domain | CAMSAP_CH | 6.33e-04 | 7 | 104 | 2 | IPR022613 | |
| Domain | Elp3/MiaB/NifB | 6.33e-04 | 7 | 104 | 2 | IPR006638 | |
| Domain | - | 8.41e-04 | 8 | 104 | 2 | 3.90.290.10 | |
| Domain | - | 1.06e-03 | 207 | 104 | 6 | 1.25.40.10 | |
| Domain | rSAM | 1.08e-03 | 9 | 104 | 2 | IPR007197 | |
| Domain | Alpha_adaptinC2 | 1.08e-03 | 9 | 104 | 2 | PF02883 | |
| Domain | TB_dom | 1.08e-03 | 9 | 104 | 2 | IPR017878 | |
| Domain | Radical_SAM | 1.08e-03 | 9 | 104 | 2 | PF04055 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.08e-03 | 9 | 104 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.08e-03 | 9 | 104 | 2 | SM00809 | |
| Domain | TB | 1.08e-03 | 9 | 104 | 2 | PS51364 | |
| Domain | LAM_G_DOMAIN | 1.23e-03 | 38 | 104 | 3 | PS50025 | |
| Domain | AAA | 1.27e-03 | 144 | 104 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.27e-03 | 144 | 104 | 5 | IPR003593 | |
| Domain | Laminin_G_2 | 1.43e-03 | 40 | 104 | 3 | PF02210 | |
| Domain | Laminin_G_1 | 1.63e-03 | 11 | 104 | 2 | PF00054 | |
| Domain | LamG | 1.88e-03 | 44 | 104 | 3 | SM00282 | |
| Domain | TPR-like_helical_dom | 1.94e-03 | 233 | 104 | 6 | IPR011990 | |
| Domain | Armadillo | 2.28e-03 | 47 | 104 | 3 | IPR000225 | |
| Domain | Cyclin_C-dom | 3.95e-03 | 17 | 104 | 2 | IPR004367 | |
| Domain | Cyclin_C | 3.95e-03 | 17 | 104 | 2 | PF02984 | |
| Domain | Cyclin_C | 3.95e-03 | 17 | 104 | 2 | SM01332 | |
| Domain | Laminin_G | 4.14e-03 | 58 | 104 | 3 | IPR001791 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.83e-05 | 12 | 73 | 3 | MM1526 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 7.68e-05 | 44 | 73 | 4 | M11911 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 RANBP10 TRPM4 TPST2 ABCA2 TRIO HECTD4 SREBF1 LMTK2 RAPGEF1 CUL9 NCLN CCND3 JAK3 THADA NFATC1 PROM2 NLRC5 HERC1 HTT | 1.62e-10 | 1105 | 107 | 20 | 35748872 |
| Pubmed | SEL1L MON2 RANBP10 USE1 MYO19 RNF213 COPG2 GOLPH3 UNC45A IPO4 NCLN CCND3 GSTP1 NBAS THADA COMMD4 PELP1 AP2B1 CCDC47 CUX1 PML | 2.59e-09 | 1440 | 107 | 21 | 30833792 | |
| Pubmed | 1.59e-07 | 193 | 107 | 8 | 19343046 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 17113562 | ||
| Pubmed | 1.67e-06 | 183 | 107 | 7 | 23956138 | ||
| Pubmed | MON2 HDAC6 ZNF618 GAS6 CUL9 RNF213 TF ABCA8 PARS2 LRIG3 THADA FBN2 ASPM VAV1 PML | 1.72e-06 | 1116 | 107 | 15 | 31753913 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TRPM4 USE1 ELP3 GSTP1 LRIG3 THADA AP1B1 P4HB STOML1 CDK5RAP1 HERC1 SLC23A2 | 2.30e-06 | 719 | 107 | 12 | 35337019 |
| Pubmed | 2.48e-06 | 481 | 107 | 10 | 28190767 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L TPST2 COL7A1 ABCA2 LAMA1 SREBF1 RNF213 NCLN THADA FBN1 FBN2 P4HB CCDC47 DNASE1L1 HTT | 4.19e-06 | 1201 | 107 | 15 | 35696571 |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12399449 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21851253 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 9.38e-06 | 2 | 107 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 9.38e-06 | 2 | 107 | 2 | 21440062 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15131124 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 9.38e-06 | 2 | 107 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 9.38e-06 | 2 | 107 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 9.38e-06 | 2 | 107 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 9.38e-06 | 2 | 107 | 2 | 7744963 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 9.38e-06 | 2 | 107 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 9.38e-06 | 2 | 107 | 2 | 24833718 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24265020 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20529844 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23133647 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 32918123 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 9.38e-06 | 2 | 107 | 2 | 1852206 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12429739 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 9.38e-06 | 2 | 107 | 2 | 12524050 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8120105 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 9.38e-06 | 2 | 107 | 2 | 10504303 | |
| Pubmed | SEL1L degradation intermediates stimulate cytosolic aggregation of polyglutamine-expanded protein. | 9.38e-06 | 2 | 107 | 2 | 33576152 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 33532735 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 9.38e-06 | 2 | 107 | 2 | 25524144 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 9.38e-06 | 2 | 107 | 2 | 16407178 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 10359653 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24584466 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPM4 IL17REL TRIO GAS6 HECTD4 RNF213 CCND3 EXD3 THADA NFATC1 PROM2 SLC19A1 CDK5RAP1 NLRC5 CUX1 HTT | 1.29e-05 | 1489 | 107 | 16 | 28611215 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.81e-05 | 104 | 107 | 5 | 31240132 | |
| Pubmed | MON2 HDAC6 MYO19 UNC45A IPO4 NCLN PARS2 NFATC1 CCDC47 CDK5RAP1 | 1.85e-05 | 606 | 107 | 10 | 36538041 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.23e-05 | 18 | 107 | 3 | 39040056 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.27e-05 | 183 | 107 | 6 | 31932471 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 10825173 | ||
| Pubmed | HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. | 2.81e-05 | 3 | 107 | 2 | 16192271 | |
| Pubmed | Selective activation of NFAT by promyelocytic leukemia protein. | 2.81e-05 | 3 | 107 | 2 | 18246125 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 30201140 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17250723 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 12884293 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 31875875 | ||
| Pubmed | Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism. | 2.81e-05 | 3 | 107 | 2 | 24039232 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20855508 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 33707149 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 29384425 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20137387 | ||
| Pubmed | A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer. | 2.81e-05 | 3 | 107 | 2 | 31433512 | |
| Pubmed | 3.11e-05 | 20 | 107 | 3 | 21072184 | ||
| Pubmed | 3.62e-05 | 21 | 107 | 3 | 23137377 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.96e-05 | 202 | 107 | 6 | 33005030 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L MON2 RANBP10 UNC45A IPO4 NCLN ELP3 TF FBN2 AP1B1 AP2B1 P4HB | 4.70e-05 | 974 | 107 | 12 | 28675297 |
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 5.60e-05 | 4 | 107 | 2 | 25406291 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 20729550 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 5.60e-05 | 4 | 107 | 2 | 25034023 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 20656020 | ||
| Pubmed | Characterization of murine CD70 by molecular cloning and mAb. | 5.60e-05 | 4 | 107 | 2 | 9620608 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 19469909 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 10639163 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 7534311 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 12429738 | ||
| Pubmed | Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis. | 5.60e-05 | 4 | 107 | 2 | 17290217 | |
| Pubmed | Non-enzymatic developmental functions of acetylcholinesterase--the question of redundancy. | 5.60e-05 | 4 | 107 | 2 | 18785927 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 16835936 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 25526803 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 9707615 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 6.99e-05 | 26 | 107 | 3 | 34189436 | |
| Pubmed | 7.85e-05 | 27 | 107 | 3 | 11463741 | ||
| Pubmed | 8.76e-05 | 457 | 107 | 8 | 22190034 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 8.77e-05 | 28 | 107 | 3 | 31600191 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 26601954 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 17536768 | ||
| Pubmed | Activating mutations in human acute megakaryoblastic leukemia. | 9.32e-05 | 5 | 107 | 2 | 18755984 | |
| Pubmed | Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. | 9.32e-05 | 5 | 107 | 2 | 12532264 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 17180579 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 9.32e-05 | 5 | 107 | 2 | 23493297 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 34852225 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 19892789 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 12590922 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 28507509 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 18690546 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 17255108 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 34411563 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 9169408 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 16723738 | ||
| Pubmed | 1.04e-04 | 150 | 107 | 5 | 32423001 | ||
| Pubmed | 1.08e-04 | 30 | 107 | 3 | 20301299 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.15e-04 | 754 | 107 | 10 | 33060197 | |
| Pubmed | 1.20e-04 | 31 | 107 | 3 | 22282597 | ||
| Pubmed | GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles. | 1.32e-04 | 32 | 107 | 3 | 34473204 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 18668520 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 18618215 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 10966473 | ||
| Interaction | C3orf52 interactions | TRPM4 ABCA2 USE1 SREBF1 RDH14 COPG2 FAAH NBAS TMEM168 SLC23A2 CUX1 PML | 5.21e-08 | 305 | 103 | 12 | int:C3orf52 |
| Interaction | TOP3B interactions | MON2 RANBP10 TRPM4 TPST2 ABCA2 TRIO HECTD4 SREBF1 LMTK2 RAPGEF1 CUL9 UNC45A IPO4 NCLN CCND3 CCNF JAK3 THADA PELP1 NFATC1 PROM2 NLRC5 HERC1 HTT | 2.78e-07 | 1470 | 103 | 24 | int:TOP3B |
| Interaction | TRIM66 interactions | 1.08e-06 | 205 | 103 | 9 | int:TRIM66 | |
| Interaction | GPR182 interactions | MON2 ABCA2 MYO19 ABCB6 RNF213 NCLN FAAH THADA HEATR6 CCDC47 CUX1 HTT | 3.62e-06 | 455 | 103 | 12 | int:GPR182 |
| Interaction | AP1G1 interactions | 1.20e-05 | 150 | 103 | 7 | int:AP1G1 | |
| Interaction | ABCA6 interactions | 1.52e-05 | 10 | 103 | 3 | int:ABCA6 | |
| Interaction | FAM174A interactions | 1.97e-05 | 224 | 103 | 8 | int:FAM174A | |
| Interaction | P2RY6 interactions | 2.80e-05 | 385 | 103 | 10 | int:P2RY6 | |
| Interaction | FLOT1 interactions | SEL1L LAMTOR2 HDAC6 TRIO MYO19 LMTK2 RAPGEF1 SLC19A1 CNTNAP2 VAV1 HTT | 3.15e-05 | 475 | 103 | 11 | int:FLOT1 |
| Interaction | ARFGAP1 interactions | 6.79e-05 | 135 | 103 | 6 | int:ARFGAP1 | |
| GeneFamily | ATP binding cassette subfamily A | 1.72e-05 | 14 | 67 | 3 | 805 | |
| GeneFamily | BCL2 family | 1.20e-03 | 14 | 67 | 2 | 1057 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.49e-06 | 194 | 107 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.49e-06 | 194 | 107 | 6 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.94e-06 | 196 | 107 | 6 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.17e-06 | 197 | 107 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.17e-06 | 197 | 107 | 6 | 6b6440f1baad5680cf9e13ca3ab72a2c65523d59 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.91e-06 | 200 | 107 | 6 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 4.91e-05 | 165 | 107 | 5 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.05e-05 | 166 | 107 | 5 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.05e-05 | 166 | 107 | 5 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 5.35e-05 | 168 | 107 | 5 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-05 | 169 | 107 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 173 | 107 | 5 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 173 | 107 | 5 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 173 | 107 | 5 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-05 | 175 | 107 | 5 | 901f0181a30e5cc609dcada8d8a59f0468df6fa5 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 6.66e-05 | 176 | 107 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.84e-05 | 177 | 107 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 6.84e-05 | 177 | 107 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.84e-05 | 177 | 107 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.22e-05 | 179 | 107 | 5 | 8d9bad6507fac0926163807a0bda62a57e7660e3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-05 | 182 | 107 | 5 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.01e-05 | 183 | 107 | 5 | ab38264daddccdf5ffb75ff2210b27423eca6bc0 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.01e-05 | 183 | 107 | 5 | e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.01e-05 | 183 | 107 | 5 | 263bfa1d8a7314bc3156c735c403c3bab8ea4dac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 183 | 107 | 5 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.01e-05 | 183 | 107 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-05 | 184 | 107 | 5 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 186 | 107 | 5 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-05 | 187 | 107 | 5 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.09e-05 | 188 | 107 | 5 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 189 | 107 | 5 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 189 | 107 | 5 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 9.56e-05 | 190 | 107 | 5 | 5ec49cc7692053c1a525ca9137c996ccd2794e1c | |
| ToppCell | ILEUM-inflamed-(5)_IgG_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.56e-05 | 190 | 107 | 5 | 76baa41b217ae6fd62a58971912e8ecfe1dc03e7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-05 | 190 | 107 | 5 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-05 | 191 | 107 | 5 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.80e-05 | 191 | 107 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | Adult-Immune-natural_killer_cell|Adult / Lineage, Cell type, age group and donor | 9.80e-05 | 191 | 107 | 5 | 758ec27e47d7662a5175305e98a1506c6859dbf7 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.80e-05 | 191 | 107 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-05 | 191 | 107 | 5 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.00e-04 | 192 | 107 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 192 | 107 | 5 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-04 | 192 | 107 | 5 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.03e-04 | 193 | 107 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 194 | 107 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.05e-04 | 194 | 107 | 5 | 69828d24b3e182f26aa15eb0ae5aa21c640c2922 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 195 | 107 | 5 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 195 | 107 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 195 | 107 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 195 | 107 | 5 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 195 | 107 | 5 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 196 | 107 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 196 | 107 | 5 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-04 | 197 | 107 | 5 | 032ccc91e604113da9bc34a6f9ddb1d45dea1892 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 197 | 107 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.13e-04 | 197 | 107 | 5 | 3b1c574b3d119b63967bb1306f0353ecc4c522f3 | |
| ToppCell | B_cells-Plasmablasts|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.16e-04 | 198 | 107 | 5 | c6cab47885be74a64351f843a741dea6d911bde4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 198 | 107 | 5 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | 5a29db2610ba06a2248325a16cad755d20debf2c | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | 6150b272313d3fbf5ddcb3a8d51862d368220fe2 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 1.19e-04 | 199 | 107 | 5 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-04 | 199 | 107 | 5 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-04 | 199 | 107 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 1.19e-04 | 199 | 107 | 5 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | Caecum-(2)_B_cell-(20)_B_cell_IgA_Plasma|Caecum / shred on region, Cell_type, and subtype | 1.19e-04 | 199 | 107 | 5 | 76b3c2ee5da8ddc214e5919b5804dfedcbb60d30 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Caecum-B_cell-B_cell_IgA_Plasma|Caecum / Region, Cell class and subclass | 1.19e-04 | 199 | 107 | 5 | 49c19601566205f41f04bfb5714f865398482d39 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 199 | 107 | 5 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.22e-04 | 200 | 107 | 5 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.22e-04 | 200 | 107 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 200 | 107 | 5 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 200 | 107 | 5 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 200 | 107 | 5 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 200 | 107 | 5 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 200 | 107 | 5 | 2bd8c35484fe6b0bc0f9314216786baaa97d1e95 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 200 | 107 | 5 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 200 | 107 | 5 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 200 | 107 | 5 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Sepsis-Int-URO-Myeloid-tDC|Int-URO / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | f5d0497a72da21cad24e0ef51c3dc4d024dbf294 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 200 | 107 | 5 | 94bd00fb6ff0dcb668eb36ec2085f1c3128855b6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.22e-04 | 200 | 107 | 5 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.22e-04 | 200 | 107 | 5 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 200 | 107 | 5 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.22e-04 | 200 | 107 | 5 | 8472baa74c48b67c5f08223025885c833458290b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.22e-04 | 200 | 107 | 5 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | (21)_B_cell_IgG_Plasma|World / shred on Cell_type and subtype | 1.30e-04 | 203 | 107 | 5 | 15055e1b1017afbdb2a567972cbb976deb7d4e6a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 119 | 107 | 4 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.15e-04 | 135 | 107 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | droplet-Liver-Npc-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 155 | 107 | 4 | d883a3869cf893d62741f26f641ed3923aba03f9 | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 3.44e-06 | 195 | 105 | 8 | 630_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 4.15e-06 | 200 | 105 | 8 | 5212_DN | |
| Disease | Colorectal Neoplasms | 6.00e-06 | 277 | 103 | 8 | C0009404 | |
| Disease | Colorectal Carcinoma | COL7A1 LAMA1 ABCB6 PBX4 ABCA8 FBN2 NFATC1 ABCA6 SLC19A1 WNT16 CUX1 SMAD4 | 6.35e-06 | 702 | 103 | 12 | C0009402 |
| Disease | connective tissue disease (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | lymphocyte count | SEL1L RANBP10 AMZ1 GAS6 HECTD4 SREBF1 PBX4 NCLN ADCY5 CCND3 THADA FBN1 NFATC1 NLRC5 VAV1 HTT | 4.70e-05 | 1464 | 103 | 16 | EFO_0004587 |
| Disease | obsolete_red blood cell distribution width | MYO19 GAS6 HECTD4 ABCB6 PBX4 HSD11B1L TF CCND3 CCNF FBN2 AP2B1 ABCA6 SLC19A1 HERC1 SLC23A2 | 6.75e-05 | 1347 | 103 | 15 | EFO_0005192 |
| Disease | scoliosis (is_implicated_in) | 7.21e-05 | 4 | 103 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Parkinson Disease | 2.28e-04 | 85 | 103 | 4 | C0030567 | |
| Disease | multiple myeloma (is_marker_for) | 2.71e-04 | 36 | 103 | 3 | DOID:9538 (is_marker_for) | |
| Disease | reticulocyte count | USE1 CYP27A1 HECTD4 ABCB6 CCND3 THADA AP1B1 AP2B1 SLC19A1 HERC1 SLC23A2 CUX1 | 2.89e-04 | 1045 | 103 | 12 | EFO_0007986 |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Acute kidney injury | 4.41e-04 | 101 | 103 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 4.41e-04 | 101 | 103 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 4.41e-04 | 101 | 103 | 4 | C0022660 | |
| Disease | sexual dimorphism measurement | RANBP10 COL7A1 AMZ1 ABCA8 CCND3 SSC5D FBN1 BOK COMMD4 CDK5RAP1 NLRC5 HERC1 | 4.81e-04 | 1106 | 103 | 12 | EFO_0021796 |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 5.48e-04 | 107 | 103 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | visual epilepsy (is_implicated_in) | 6.50e-04 | 11 | 103 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 6.70e-04 | 301 | 103 | 6 | DOID:684 (is_marker_for) | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 6.77e-04 | 49 | 103 | 3 | EFO_0021897 | |
| Disease | Huntington Disease, Late Onset | 7.78e-04 | 12 | 103 | 2 | C0393574 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 7.78e-04 | 12 | 103 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 7.78e-04 | 12 | 103 | 2 | C0751208 | |
| Disease | ADHD symptom measurement | 7.78e-04 | 12 | 103 | 2 | EFO_0007860 | |
| Disease | Adenocarcinoma of lung (disorder) | 7.95e-04 | 206 | 103 | 5 | C0152013 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.52e-04 | 53 | 103 | 3 | C4707243 | |
| Disease | hematologic cancer (implicated_via_orthology) | 9.18e-04 | 13 | 103 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Manganese Poisoning | 1.07e-03 | 14 | 103 | 2 | C0677050 | |
| Disease | tea consumption measurement | 1.10e-03 | 129 | 103 | 4 | EFO_0010091 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.17e-03 | 59 | 103 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | FEV/FEC ratio | AMZ1 RDH14 THADA FBN1 TTC7B NFATC1 SLC19A1 WNT16 CNTNAP2 HERC1 CUX1 PML | 1.19e-03 | 1228 | 103 | 12 | EFO_0004713 |
| Disease | macrophage inflammatory protein 1b measurement | 1.34e-03 | 136 | 103 | 4 | EFO_0008219 | |
| Disease | HETE measurement | 1.35e-03 | 62 | 103 | 3 | EFO_0801166 | |
| Disease | neutrophil percentage of leukocytes | 1.36e-03 | 610 | 103 | 8 | EFO_0007990 | |
| Disease | filaggrin gene expression measurement | 1.40e-03 | 16 | 103 | 2 | EFO_0020899 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.59e-03 | 17 | 103 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Huntington Disease | 1.59e-03 | 17 | 103 | 2 | C0020179 | |
| Disease | MHPG measurement, 5-HIAA measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | physical activity measurement | 1.71e-03 | 245 | 103 | 5 | EFO_0008002 | |
| Disease | non-alcoholic steatohepatitis (is_marker_for) | 1.78e-03 | 18 | 103 | 2 | DOID:0080547 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.78e-03 | 147 | 103 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.91e-03 | 70 | 103 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.91e-03 | 70 | 103 | 3 | C3241937 | |
| Disease | urinary microalbumin measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0010967 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.37e-03 | 264 | 103 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | kidney disease (biomarker_via_orthology) | 2.43e-03 | 21 | 103 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | Disease Exacerbation | 2.71e-03 | 165 | 103 | 4 | C0235874 | |
| Disease | apolipoprotein A 1 measurement | 2.90e-03 | 848 | 103 | 9 | EFO_0004614 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 3.17e-03 | 24 | 103 | 2 | EFO_0003761, EFO_0005658 | |
| Disease | Drug toxicity | 3.21e-03 | 84 | 103 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 3.21e-03 | 84 | 103 | 3 | C0041755 | |
| Disease | Dystonia | 3.43e-03 | 86 | 103 | 3 | C0013421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVDILMDLGALARNC | 276 | P49682 | |
| LLGAVCMLLASKLRE | 101 | P30281 | |
| LIRALAVRTMGCIRV | 101 | P63010 | |
| RCLMQGALSLDEALR | 276 | Q400G9 | |
| MLCVAGARLKRELDA | 1 | P39880 | |
| DRVAIMVSGRLRCIG | 1481 | Q8N139 | |
| IGSAIQRLRCELDIM | 301 | Q96SW2 | |
| LICLGLMGLERALNV | 266 | Q9NP58 | |
| LIRALAVRTMGCIRV | 101 | Q10567 | |
| AAVGVILIMAVLCNR | 276 | O95622 | |
| VNVAITMCVLGLRDR | 201 | Q7Z5J1 | |
| VCAVLLRLGDELEMI | 66 | Q9UMX3 | |
| DLQCGVRLVRTMELL | 971 | Q8IZT6 | |
| RALMCVAVALSLIAL | 81 | P56750 | |
| ALGQASECLRLMARA | 591 | Q6VN20 | |
| ECLSLAVLDLARMAR | 161 | P52333 | |
| AAEVLSRRCVLMRLL | 76 | Q969V3 | |
| RVARIMVCGRIALAK | 231 | Q6ZWB6 | |
| CLGMSEFLRALGRRV | 26 | Q9H9Y4 | |
| IEGMRLVCRLAREVL | 136 | P53582 | |
| LMEQLRLLVCERASL | 26 | O95751 | |
| DGCAMLLRVRASITL | 21 | Q6ZVW7 | |
| DLTIRAGAMARLECA | 611 | Q6UXM1 | |
| RIRMACLAAKELDGV | 821 | Q96H55 | |
| LVRVLSAMLFLLIGC | 166 | Q9NYG8 | |
| LVRLMCLAAAGRAGL | 3221 | Q15751 | |
| GRVCCEGMLIQLRFL | 211 | Q96A33 | |
| LRALACLPAVMLAAR | 66 | Q9NS67 | |
| MRALRDRAGLLLCVL | 1 | Q6H9L7 | |
| CRRMGVNAERSLLIL | 6 | A0A0J9YX94 | |
| SGVLLAMALDRCVAI | 116 | A6NMU1 | |
| IMSLVGVLRRLAACR | 256 | Q96G04 | |
| SMRAVIDCAGILKLR | 526 | O95644 | |
| RRAIMGFLEEILAVC | 1151 | Q6AI08 | |
| LLQRMACEVAAGLAA | 241 | Q8IWU2 | |
| MLRRALLCLAVAALV | 1 | P07237 | |
| ILKAELTMAALCGRL | 581 | Q7Z3U7 | |
| AVMALDRAAAVCRPL | 116 | Q8NGU4 | |
| LVRSGLVQLMDRLCS | 1286 | Q9Y4D8 | |
| VCAAALRGLSRTILM | 521 | Q8IZL8 | |
| VEMLILGRLVIGLFC | 141 | Q8TDB8 | |
| DCALSLIRLGMERNI | 861 | A2RRP1 | |
| TFEECVLGLAMVRLR | 446 | Q86UA1 | |
| ESLVLCRRLEELMLG | 1656 | Q86WI3 | |
| ALRGRRLALGLCMAA | 186 | Q96RI0 | |
| LLRLDNMLLAEGVCR | 81 | Q9BYU1 | |
| LGMCNREIVRRGALI | 1886 | P42858 | |
| DTLVRILARCDIMVL | 41 | P49184 | |
| RLQLLGIACMVICTR | 351 | P41002 | |
| MTLDATGRICLDIRL | 941 | P35555 | |
| RACLGEPLARMELFL | 441 | P10635 | |
| RGCMTLEVNRRLLDL | 641 | Q14393 | |
| CLGRRIAELEMQLLL | 476 | Q02318 | |
| ALRRVLECLASGIVM | 271 | Q12906 | |
| SSGLRGCMLIELALR | 86 | Q9H4A6 | |
| GCMLIELALRGRLQL | 91 | Q9H4A6 | |
| VRGRCAALRMLLADQ | 11 | P09211 | |
| LCTRLAIMVNGRLRC | 2251 | Q9BZC7 | |
| LRVCSLRMNRLAGVG | 121 | Q9H0A8 | |
| RALCRITDGTMLQAI | 126 | Q9UBF2 | |
| LALARMKDLGIQCRD | 386 | Q9H9T3 | |
| CMEGRVAITRVANLL | 76 | Q9Y2Q5 | |
| RADCLSTGMELLRRI | 2401 | Q8IWT3 | |
| MTLRLLVAALCAGIL | 1 | Q02388 | |
| CIRSLRMNGVTLDLE | 936 | Q9UHC6 | |
| GPMARDVESLALCLR | 281 | O00519 | |
| RILRIMCRLEELGLA | 506 | Q9UBN7 | |
| LTLDGTGRVCLDIRM | 986 | P35556 | |
| RVRDNICGALARLLM | 956 | Q8TEX9 | |
| LVLRGMDSEVLSCRI | 1351 | A6NES4 | |
| MEGLLTRCRALPALA | 1 | Q7L3T8 | |
| MRQLCRGRVLGISVA | 1 | Q5M8T2 | |
| RGALGALMACLRIAR | 591 | Q6YHU6 | |
| MLRKAECLVALGRLQ | 146 | Q8IYR2 | |
| MRVRIGLTLLLCAVL | 1 | Q9UBV2 | |
| ALLRAELMCTLREVR | 431 | Q5SWL7 | |
| MRPGCDLLLRAAATV | 1 | Q8IZX4 | |
| AVLAMRDLCRLLEVS | 746 | P29590 | |
| MRGGVLLVLLLCVAA | 1 | P25391 | |
| GVDDLRRLCILRMSF | 491 | Q13485 | |
| AELLRLGARVIMGCR | 61 | Q9HBH5 | |
| MRVLACLLAALVGIQ | 1 | A1L4H1 | |
| RLAATIIICIGFLLM | 456 | A4IF30 | |
| GMLDRSRLALCTLVF | 481 | P36956 | |
| DRVAIMVSGRLRCIG | 1486 | O94911 | |
| CSFDVAIIAGRLRML | 46 | Q5TBC7 | |
| LRIGILGCMAERLKE | 176 | Q96SZ6 | |
| CRMIRLLSLVDSAGQ | 876 | Q63HN8 | |
| LELNLVRLLSRCEAM | 6 | Q9NZ43 | |
| MRLSVRRVLLAAGCA | 1 | O60704 | |
| ERLLRVMCADLGALS | 471 | Q5T7W0 | |
| MRLAVGALLVCAVLG | 1 | P02787 | |
| LLMELVFRLVCNGEL | 781 | Q13905 | |
| RRVIQCGAALMLALG | 456 | Q9UGH3 | |
| ALACERAALMVFLLL | 146 | Q8N271 | |
| VVEMAEADLRALLCR | 351 | Q9UBI4 | |
| LRLALDAMRDLAQCV | 356 | P15498 | |
| MLLVALGILCAFRRL | 156 | P47872 | |
| ALRVACGDSVLARML | 241 | P41440 | |
| MEAARALRLLLVVCG | 1 | Q7L0X0 | |
| MASEVVCGLIFRLLL | 1 | Q9H5I5 | |
| MDRAALLGLARLCAL | 1 | Q9UBV4 | |
| ICRRLSVVFAGMIEL | 261 | Q9H0V1 | |
| IARQLAEILLRGMCE | 261 | Q86TV6 | |
| LGRCRMALLLAVALD | 31 | C9JI98 | |
| LMLAALRTLVGICSE | 211 | Q9H3U1 | |
| VSSALGACLLLRVMA | 586 | Q8TD43 | |
| ILVLEMADQGRLLDC | 2866 | O75962 | |
| LARSLRCLGVDARML | 641 | Q8N9H8 |